Bayer To Withdraw Essure Contraceptive Implants In US
Sumaira FH Published July 23, 2018 | 04:21 PM
German chemicals and pharmaceuticals giant Bayer will withdraw its controversial Essure contraceptive implants from sale in the United States, the last country where they are available, more than a year after they were discontinued in Europe.
Frankfurt am Main, (APP - UrduPoint / Pakistan Point News - 23rd Jul, 2018 ) :German chemicals and pharmaceuticals giant Bayer will withdraw its controversial Essure contraceptive implants from sale in the United States, the last country where they are available, more than a year after they were discontinued in Europe.
Bayer's decision to stop sales on December 31 "is based on a decline in US sales of Essure in recent years," the group said in a statement Friday, while insisting on its "safety and efficacy".
Essure, a non-hormonal coil implant used to sterilise women, has in some women caused chronic pain, perforation of the uterus and fallopian tubes and led to hysterectomies, news reports say.
Bayer blamed a number of factors for lower sales, including "decreased use of permanent contraception overall, increased reliance on other birth control options... and inaccurate and misleading publicity about the device." A tiny spring-shaped device, Essure is inserted under local anaesthetic into the fallopian tubes, blocking them in order to prevent fertilisation.
It can be performed in the physician's office.
Its withdrawal from sale in Europe last year followed European Union authorities' suspension of sales of the implant while they gathered more data on safety.
But while the US food and Drug Administration (FDA) required Bayer in April to limit sales of Essure to medical practitioners who agreed to run through a checklist of the risks with patients before selling them the implant, it did not at any point stop sales.
"The FDA continues to believe that the benefits of the device outweigh its risks," the authority says on its website.
It nevertheless adds that between November 2002 and January 2018, there were 26,773 "adverse event and product problem reports" submitted about Essure according to its database.
The most common problems women reported were pain, heavier periods, headaches, fatigue and weight fluctuations, with most reports cataloguing multiple symptoms in a single patient.
Related Topics
Recent Stories
Punjab CM Maryam Nawaz in police uniform at Chung police center
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 25 April 2024
Today Gold Rate in Pakistan 25 April 2024
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
Osaka seals first win on clay since 2022 in Madrid
More Stories From World
-
US Supreme Court to hear Trump immunity claim
18 minutes ago -
Blinken calls for US, China to manage differences 'responsibly'
48 minutes ago -
Norway oil giant Equinor's profit falls on lower gas prices
49 minutes ago -
N. Macedonia's right-wing presidential candidate wins 1st round
1 hour ago -
Vietnam court jails soft drinks tycoon in $40 million scam case
1 hour ago -
The guardian angels of the source of the Seine
1 hour ago
-
Star Dudamel brings inclusive vision to New York Philharmonic
2 hours ago -
Paris dream of swimming in the Seine finally within reach
3 hours ago -
Portugal's Carnation Revolution, 50 years on
3 hours ago -
Tough times for Argentine factories as consumers penny-pinch
3 hours ago -
Use of alcohol and e-cigarettes among youth 'alarming': WHO
3 hours ago -
Football: Italian Cup result
3 hours ago